| __timestamp | Ionis Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 520990000000 |
| Thursday, January 1, 2015 | 322292000 | 535405000000 |
| Friday, January 1, 2016 | 344320000 | 558755000000 |
| Sunday, January 1, 2017 | 374644000 | 495921000000 |
| Monday, January 1, 2018 | 1820000 | 659690000000 |
| Tuesday, January 1, 2019 | 4000000 | 1089764000000 |
| Wednesday, January 1, 2020 | 12000000 | 994308000000 |
| Friday, January 1, 2021 | 11000000 | 1106846000000 |
| Saturday, January 1, 2022 | 14000000 | 1244072000000 |
| Sunday, January 1, 2023 | 9133000 | 1431505000000 |
| Monday, January 1, 2024 | 11215000 | 1431505000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, cost efficiency is a critical metric for success. This analysis compares the cost of revenue efficiency between Takeda Pharmaceutical Company Limited and Ionis Pharmaceuticals, Inc. over the past decade. Takeda, a global leader, consistently reported a cost of revenue exceeding $500 billion annually, peaking at approximately $1.43 trillion in 2023. In contrast, Ionis, a smaller biotech firm, maintained a cost of revenue below $400 million, with a notable dip to $1.82 million in 2018. This stark contrast highlights Takeda's expansive operations and Ionis's leaner approach. Despite the missing data for Ionis in 2024, the trend underscores the diverse strategies these companies employ to manage costs. As the pharmaceutical landscape continues to shift, understanding these dynamics is crucial for investors and industry stakeholders alike.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
GSK plc vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs MiMedx Group, Inc.